Scalable flow synthesis of ultrasmall inorganic nanoparticles for biomedical applications via a confined impinging jet mixer
- PMID: 41748858
- DOI: 10.1038/s41598-026-41509-z
Scalable flow synthesis of ultrasmall inorganic nanoparticles for biomedical applications via a confined impinging jet mixer
Keywords: Cerium oxide; Iron oxide; Microfluidics; Nanoparticles; Silver sulfide; Silver telluride.
Conflict of interest statement
Declarations. Competing interests: DPC and ADAM are named as inventors on patent applications concerning silver-based contrast agents. They also hold stock in Daimroc Imaging, a company that is seeking to commercialize such agents. DPC and HK are named as inventors on patent applications concerning iron oxide-based nanoparticles. DI is named as an inventor on patent applications concerning methods of microfluidic nanoparticle production.
References
-
- Anselmo, A. C. & Mitraotri, S. A. Review of clinical translation of inorganic nanoparticles. AAPS J. 17, 5, 1041–1054 (2015).
-
- Huang, H. C., Barua, S., Sharma, G., Dey, S. K. & Rege, K. Inorganic nanoparticles for cancer imaging and therapy. J. Controlled Release. 155, 3, 344–357 (2011).
-
- Kim, T. & Hyeon, T. Applications of inorganic nanoparticles as therapeutic agents. Nanotechnology 25, 1, 012001 (2014).
-
- Zarschlet, K. et al. Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications. Nanomedicine 12, 6, 1663–1701 (2016).
-
- Ehlerding, E. B., Chen, F. & Cai, W. Biodegradable and renal clearable inorganic nanoparticles. Adv Sci. (Weinheim Ger). 3, 1500223 (2016).
Grants and funding
LinkOut - more resources
Full Text Sources
